← Back to homepage
Google DeepMind’s London AI drug spinout eyes $50bn valuation
Sources
1
Coverage
Limited spectrum
Sentiment
0.00
◀ Left 0%Centre 100%Right 0% ▶
How we rate bias →This story is currently only covered by one source from a single part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.
NewsDeck Poll
Do you think this story is being covered fairly across the political spectrum?
Loading…
Left
(0)
No coverage from this perspective yet
Centre
(1)
City AM
Google DeepMind’s London AI drug spinout eyes $50bn valuation
London-based AI drug discovery firm, Isomorphic Labs, is reportedly seeking a valuation of up to $50bn (£37bn) in fresh funding talks, just five months after raising $2.1bn from investors. The Google DeepMind spinout, led by Nobel Prize-winning scientist Sir Demis Hassabis, is in early discussions to raise new capital at a valuation of at least [...]
8 Oct, 12:05
Right
(0)
No coverage from this perspective yet